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Identity 
Other names: MIRN10B (microRNA 10b): MIR10B; 
hsa-mir-10b; mir-10b 
HGNC (Hugo): MIR10B 
Location: 2q31.1 
Local order: Based on Mapviewer Genes on 
Sequence, genes flanking MIRN10B oriented from 
centromere to telomere on 2q31.1 are:  
HOXD11; Homeobox 11, 2q31.1  
HOXD 10; Homeobox 10, 2q31.1  
HOXD 9; Homeobox 9, 2q31.1  
HOXD 8; Homeobox 8, 2q31.1  
MIRN10B; microRNA 10b, 2q31.1  
HOXD 4; Homeobox 4, 2q31.1  
HOXD 3; Homeobox3, 2q31.1  
MTX2; Metaxin 2, 2q31.1. 
DNA/RNA 
 
Stem-loop structure of mir-10b. 
Description 
In human, microRNA-10 gene has been duplicated. It is 
now present in the form of two variants as miR-10a and
miR-10b located on different chromosomes. miR-10a is 
located between HOX4B and HOX5B on 17q21, while 
miR-10b is located between HOXD4 and HOXD8 on 
2q31.1. It is believed that, there is a strong correlation 
between the specific miRs and HOX genes. MIRN10B 
maps  
to the HOXD cluster on 2q31.1. HOX genes are a 
family of transcription factor genes that play crucial 
roles during normal development and in oncogenesis. 
HOXD4 expression is deregulated in a variety of solid 
and hematopoietic cancers. 
Transcription 
miRNAs are generally transcribed by RNA polymerase 
II.  
There is limited information on how miRNA gene 
expression is regulated due to lack of basic information 
of their gene structures. Screening of miRNA putative 
promoter regions (miPPRs) revealed miPPR-10b for 
MIRN10B. TWIST1, a metastasis-promoting 
transcription factor, has been shown to induce miR-10b 
via binding to the most proximal E-box upstream of the
miR-10b hairpin region. This E-box was in the miPPR-
10b.  
Pri-miRNA (primary) mir-10b: The primary miRNA 
transcripts are called pri-miRNAs. They contain cap 
structures and poly(A) tails. If transcribed by RNA 
polymerase II, primary transcript of mir-10b is not 
known yet.  
Pre-miRNA (precursor) mir-10b: pri-miRNA 
transcripts are processed by microprocessor complex 
consisting nuclear RNase enzyme Drosha and the 
double-stranded RNA binding protein Pasha to 
generate pre-miRNAs. The precursor mir-10b is 110 
nucleotides long. Pre-miR-10b is transferred from 






Mature miR-10b: In the cytoplasm, pre-miRNA 
molecules are processed into mature miRNA by RNA-
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induced silencing complex (RISC). Mature miR-10b is 




No reported pseudogenes. 
Protein 
Note 
MicroRNAs are not translated into amino acids. 
Mutations 
Note 




Possible changes in microRNA levels; including miR-
10b, was investigated during colorectal tumorigenesis. 
There was not a significant down-regulation of 
microRNA 10b in colon tumors to suggest a potential 
role in colorectal tumorigenesis. 
Breast Cancer 
Disease 
76 breast cancers and 10 normal breast samples were 
analyzed by microRNA microarray and Northern 
Blotting to identify miRNAs whose expression is 
deregulated notably in cancer versus normal breast 
tissues. According to these results; miR-10b was one of 
the microRNAs which were down-regulated. 
Oncogenesis 
Tumor invasion and Metastasis: Although miR-10b 
was downregulated in nonmetastatic breast cancers in 
comparison with normal breast tissue, this miRNA was 
over-expressed in about 50% of metastatic breast 
cancers. Ectopic expression of miR-10b had no effect 
on proliferation, but an increase in transwell migration 
and Matrigel invasion was observed. In vivo ectopic 
expression of miR-10b conferred invasive properties on 
otherwise non-invasive breast cancer cells. Althoug 
control tumors could not invade surrounding tissues 
and exhibited poor vascularization, miR-10b over-
expressing tumors exhibited an invasive behavior and 
were highly vascularized. miR-10b promoted 
metastasis in non-metastatic breast cancer cells. Lung 
micro-metastasis was detected in miR-10b over-
expressing cells while there were no intravasating cells 
or lung metastases in control tumors.  
It was shown that miR-10b expression was induced by 
transcription factor TWIST allowing miR-10b to inhibit 
translation of the mRNA encoding homeobox D10 
(Figure 2). This resulted in increased expression of a 
well-characterized prometastatic gene, RHOC (ras 
homolog gene family member C), thus leading to 
migration, tumor invasion, and metastasis. 
Glioblastoma 
Disease 
miR-10b was one of the over-expressed miRNAs in 
glioblastomas compared to peripheral tissues. 
According to the microarray studies on glioblastomas, 
an excess of 1.97- to 13.6-fold increase was observed 
in 5 in out of 9 samples. This data was further 
confirmed by Northern blotting. miR-10b was stated o 
be a candidate oncogene microRNA as it was 
significantly upregulated in glioblastomas. 
Acute Myeloid Leukemia (AML) 
Disease 
Role of microRNAs in the biology of NPMc+ 
(nucleophosmin) AML was investigated in 85 adult de 
novo AML patients. Microarray studies characterized 
these patients for subcellular localization/mutation 
status of NPM1 and FLT3 mutations. A strong 
microRNA expression pattern was identified which 
differentiated NPMc+ mutated from the cytoplasmic-
negative (NPM1 unmutated) cases. According to this 
pattern, miRNA-10b together with miRNA-10a, let-7 
and miR-29 family members were up-regulated. These 
data was further confirmed by qRT-PCR in 44 AML 
patients (randomly chosen from the initial cohort). 
According to the overall results, it was remarkable that 
miRNA-10b and miRNA-10a expression levels clearly 
differentiated NPMc+ vs. NPMc- cases. 
Central Nervous System (CNS) tumors 
Disease 
Although, miRNA-10b was not specifically expressed 
in brain tissue, it was one of the 5 microRNAs which 
were highly expressed in CNS tumor-derived cell lines 
compared to normal brain tissue. 
 
Regulation and function of miR-10b in breast cancer metastasis. 
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Hepatocellular adenomas (HCAs) and 
Hepatocellular Carcinomas (HCCs) 
Disease 
Expression of miRNAs was analyzed in a series of 46 
malignant and benign hepatocellular tumors compared 
to 4 normal liver tissues. The most significant 
deregulated miRNAs were further analyzed in a second 
series of 43 tumors and 16 non-tumor liver tissues 
including cirrhosis and chronic hepatitis of various 
etiologies. miRNA-10b was found to be overexpressed 
in HCC when compared to benign tumors and non-
tumor liver tissues. 
Protein synthesis inhibition 
Disease 
The apolipoprotein B mRNA-editing enzyme catalytic 
polypeptide-like 3G (APOBEC3G or A3G) and other 
APOBEC family members were shown to induce 
protein synthesis by miRNAs such as miR-10b in 293T 
and HeLa cells. miRNA microarray results suggested 
overexpression of miR-10b in 293T cells. Luciferase 
assay showed A3G effects on miRNA mediated 
translational repression. A3G facilitates recruitment of 
miRNA-targeted mRNA to polysomes to synthesize 
more proteins and drives dissociation of miRNA-
targeted mRNA from P-bodies. 
Megakaryocytopoiesis 
Disease 
In order to discover regulatory pathways during 
megakaryocytic differentiation, microRNA expression 
profiling was performed for in vitro differentiated 
megakaryocytes derived from CD34+ hematopoietic 
progenitors. According to the PAM (predictive analysis 
of microarray), miR-10b was one of the microRNAs 
which were identified to be involved in megakaryocyti  
differentiation. Downregulation of miR-10b was shown 
by microarrays. But Northern blot analysis and q-RT-
PCR results showed that miR-10a and miR-130a were 




miR-10b was shown to be up-regulated during 3T3-L1 
pre-adipocyte differentiation. It was stated that this up-
regulation may not be related to an actual 
differentiation process and may be induced by growth 
arrest and/or hormonal stimulation. 
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